All In MedTech

Device Trial Radar · NCT07920926

Hypothermic Kidney Machine Perfusion With Omnisol

A Single-Center, Non-Randomized Safety Study on Hypothermic Machine Perfusion With Omnisol Preservation Solution of Deceased Donor Kidneys Prior to Transplantation

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

16

Planned (sponsor's estimate)

Start

Jan 2027

Primary completion

May 2027

Study completion May 2028

Sponsor

Lead sponsor
Vivalyx GmbHNot on our public-company list
Sponsor type
Industry
First posted
Nov 6, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Insufficient availability of organs from brain dead (DBD) and living donors has necessitated increased use of less than optimal organs from donation after cardiac death (DCD) or from extended criteria donors. Preservation of DCD organs using the current clinically applied preservation solutions is associated with up to 73% incidence of delayed graft function, highlighting the need for new preservation solutions designed to improve early graft function. Omnisol is expected to result in equivalent or improved kidney preservation as compared to currently marketed organ preservation solutions used for HMP.

Conditions

  • End Stage Renal Disease (ESRD)
  • Kidney Transplant
  • Kidney Failure
  • Renal and Urinary Tract Therapeutic Procedures

Interventions

  • Omnisol organ preservation solutionDevice

    Omnisol for HMP of DBD or DCD donors.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Delayed Graft FunctionTime frame: 7 days post-transplantation.

1 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.